Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial

Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial

Bibliographic Details
Main Authors:	Tebas P, Ramirez L, Morrow MP, Yan J, Shah D, Lee J, Weiner DB, Boyer J, Bagarazzi M, Sardesai NY
Format:	Article
Language:	English
Published:	BMC 2012-09-01
Series:	Retrovirology

Similar Items

Comparison of cellular and humoral immune responses induced by primary, consensus or mosaic HIV-1 Env DNA vaccines
by: Yan J, et al.
Published: (2012-09-01)

Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP<sup>®</sup> DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults
by: Srilatha Edupuganti, et al.
Published: (2020-12-01)

DNA vaccines expressing conserved elements provide potent and broad immune responses
by: Pavlakis GN, et al.
Published: (2012-09-01)

OA05-02. Analysis of DNA compared to Ad5 vaccination, as single and mixed modalities, demonstrates robust induction of cellular immune responses in macaques
by: Sardesai NY, et al.
Published: (2009-10-01)

Minimally invasive and surface electroporation delivery of DNA vaccines for the induction of robust humoral immune responses against HIV antigens
by: Sardesai NY, et al.
Published: (2012-09-01)

Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100
by: Matthew P Morrow, et al.
Published: (2016-01-01)

Robust antibody and cellular responses with an improved DNA vaccine alone
by: Hutnick N, et al.
Published: (2012-09-01)

Induction of nAbs and protection of mice immunized with VLP's expressing CHIKV env
by: K. Muthumani, et al.
Published: (2014-04-01)

Cellular immune responses to HIV.
by: Mcmichael, A, et al.
Published: (2001)

Innate immune cellular therapeutics in transplantation
by: Leah C. Ott, et al.
Published: (2023-03-01)

Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
by: Moon, James J., et al.
Published: (2013)

Bacterial-Derived Outer Membrane Vesicles are Potent Adjuvants that Drive Humoral and Cellular Immune Responses
by: J. Timothy Prior, et al.
Published: (2021-01-01)

Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity.
by: Francesca Avogadri, et al.
Published: (2010-09-01)

The promise and challenge of anti-HIV cellular immunity.
by: Borrow, P, et al.
Published: (2006)

Synthetic Abortive HIV-1 RNAs Induce Potent Antiviral Immunity
by: Melissa Stunnenberg, et al.
Published: (2020-01-01)

Induction of potent and long-lived antibody and cellular immune responses in the genito-rectal mucosae could be the critical determinant of HIV vaccine efficacy
by: Nadia eChanzu, et al.
Published: (2014-05-01)

Viral SERPINS—A Family of Highly Potent Immune-Modulating Therapeutic Proteins
by: Kyle Varkoly, et al.
Published: (2023-09-01)

Potent Cell-Intrinsic Immune Responses in Dendritic Cells Facilitate HIV-1-Specific T Cell Immunity in HIV-1 Elite Controllers.
by: Enrique Martin-Gayo, et al.
Published: (2015-06-01)

Role of cellular immunity in protection against HIV infection.
by: Rowland-Jones, S, et al.
Published: (1997)

An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21
by: Hyo Jung Nam, et al.
Published: (2022-04-01)

Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties
by: Talwar GP, et al.
Published: (2017-05-01)

Therapeutic immunization strategies for the control of HIV-1.
by: Dorrell, L
Published: (2005)

Potent cellular and humoral immunity against HIV-1 elicited in mice by a DNA-prime/MVA-boost vaccine regimen intended for human use
by: Biberfeldt Gunnel, et al.
Published: (2006-12-01)

The dynamics of the cellular immune response to HIV infection: implications for vaccination.
by: Mcmichael, A, et al.
Published: (2000)

A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation.
by: Michelle L Scalley-Kim, et al.
Published: (2012-01-01)

P02-02. Analysis of antigen specific degranulation potentials using IL-12 or IL-28B during HIV DNA Vaccination
by: Sardesai N, et al.
Published: (2009-10-01)

34 Novel conserved element HIV/SIV DNA vaccines maximize breadth and magnitude of immune response
by: B.K. Felber, et al.
Published: (2016-07-01)

Preclinical characterization of dostarlimab, a therapeutic anti-PD-1 antibody with potent activity to enhance immune function in in vitro cellular assays and in vivo animal models
by: Sujatha Kumar, et al.
Published: (2021-01-01)

IL-12 plus CTB in intranasal DNA-MVA schemes improved magnitude and quality of both systemic and mucosal HIV cellular immune responses
by: Rodriguez AM, et al.
Published: (2012-09-01)

The Potential of Immune Modulation in Therapeutic HIV-1 Vaccination
by: Nabila Seddiki, et al.
Published: (2020-07-01)

Immune control of HIV reservoirs and cure therapeutic strategies
by: B. Autran
Published: (2015-12-01)

Targeting Immune Checkpoint Molecules to Eliminate Latent HIV
by: Zoe Boyer, et al.
Published: (2018-10-01)

Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges
by: Sunil K. Khattar, et al.
Published: (2015-09-01)

Heterologous prime-boost cellular vaccination induces potent antitumor immunity against triple negative breast cancer
by: Seyedeh-Raheleh Niavarani, et al.
Published: (2023-02-01)

Relative rate and location of intra-host HIV evolution to evade cellular immunity are predictable.
by: Barton, J, et al.
Published: (2016)

Editorial: Extracellular vesicles as potent modulators of immunity
by: Krzysztof Bryniarski, et al.
Published: (2023-08-01)

Novel strategy for generation of mucosal immune responses against HIV-1 following systemic vaccination
by: Ugen Kenneth, et al.
Published: (2006-12-01)

Anti-HIV cellular immunity: recent advances towards vaccine design.
by: Goulder, P, et al.
Published: (1999)

Cellular and molecular insights into incomplete immune recovery in HIV/AIDS patients
by: Liting Yan, et al.
Published: (2023-05-01)

Relative rate and location of intra-host HIV evolution to evade cellular immunity are predictable
by: John P. Barton, et al.
Published: (2016-05-01)